It belongs to a newer class of metabolic therapies that target pathways similar to GLP-1 and related gut hormones
Key takeaway: GLP-1 medications like tirzepatide and semaglutide can affect the menstrual cycle, typically due to hormonal shifts related to rapid weight loss and metabolic changes
Treatment options may include: Semaglutide (Ozempic, Wegovy) Tirzepatide (Mounjaro, Zepbound) Compounded options when clinically appropriate All medications are prescribed based on your medical evaluation and monitored by a licensed provider
Although this approach might have been driven by the small sample sizes, the ROIs were heterogeneous across studies, and no clear activation patterns emerged
Sleep-deprived participants chose calorically dense foods such as chips, cookies and donuts
A medical provider can help determine if a patient would benefit from these other medications and discuss risks versus benefits with the patient